| 000 | 02505 a2200685 4500 | ||
|---|---|---|---|
| 005 | 20250514070132.0 | ||
| 264 | 0 | _c20040301 | |
| 008 | 200403s 0 0 eng d | ||
| 022 | _a1567-5769 | ||
| 024 | 7 |
_a10.1016/S1567-5769(02)00274-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOshikawa, Tetsuya | |
| 245 | 0 | 0 |
_aAnti-tumor immune response induced by the fractions derived from OK-432, a streptococcal preparation, by using a monoclonal antibody TS-2 that neutralizes the interferon-gamma-inducing activity of OK-432: comparison between the TS-2-binding and TS-2-unbinding fraction. _h[electronic resource] |
| 260 |
_bInternational immunopharmacology _cMay 2003 |
||
| 300 |
_a643-55 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xisolation & purification |
| 650 | 0 | 4 |
_aAntibodies, Neoplasm _xbiosynthesis |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aChromatography, Affinity |
| 650 | 0 | 4 | _aCulture Media |
| 650 | 0 | 4 |
_aCytokines _xbiosynthesis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHybridomas |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aInterferon Inducers _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aInterferon-gamma _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aLuciferases _xgenetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMembrane Glycoproteins _xdeficiency |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aMonocytes _xdrug effects |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPicibanil _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aReceptors, Cell Surface _xdeficiency |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aTh1 Cells _xmetabolism |
| 650 | 0 | 4 |
_aTh2 Cells _xmetabolism |
| 650 | 0 | 4 | _aToll-Like Receptor 2 |
| 650 | 0 | 4 | _aToll-Like Receptor 4 |
| 650 | 0 | 4 | _aToll-Like Receptors |
| 700 | 1 | _aOkamoto, Masato | |
| 700 | 1 | _aOhe, Go | |
| 700 | 1 | _aFuruichi, Sachiko | |
| 700 | 1 | _aNishikawa, Hidetomo | |
| 700 | 1 | _aUddin Ahmed, Sharif | |
| 700 | 1 | _aYoshida, Hideo | |
| 700 | 1 | _aMoriya, Yoichiro | |
| 700 | 1 | _aMatsubara, Shuzo | |
| 700 | 1 | _aRyoma, Yoshiki | |
| 700 | 1 | _aSaito, Motoo | |
| 700 | 1 | _aSato, Mitsunobu | |
| 773 | 0 |
_tInternational immunopharmacology _gvol. 3 _gno. 5 _gp. 643-55 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1567-5769(02)00274-6 _zAvailable from publisher's website |
| 999 |
_c12545362 _d12545362 |
||